miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6

Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker

(2014) Bente Vilming Elgaaen et al.   BMC CANCER

Let-7a Functions as a Tumor Suppressor in Ewing's Sarcoma Cell Lines Partly by Targeting Cyclin-Dependent Kinase 6

(2014) Zhongzu Zhang et al.   DNA AND CELL BIOLOGY

Cyclin-Dependent Kinase 6 Is a Chromatin-Bound Cofactor for NF-κB-Dependent Gene Expression

(2014) Katja Handschick et al.   MOLECULAR CELL

Transcription Factor/microRNA Axis Blocks Melanoma Invasion Program by miR-211 Targeting NUAK1

(2013) Rachel E. Bell et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET

(2013) T Mitamura et al.   Oncogenesis

Recurrent Amplification at 7q21.2 Targets CDK6 Gene in Primary Myxofibrosarcomas and Identifies CDK6 Overexpression as an Independent Adverse Prognosticator

(2012) Jen-Wei Tsai et al.   ANNALS OF SURGICAL ONCOLOGY

Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion

(2012) Zheng-sheng Wu et al.   BMC CANCER

WNT7A Regulates Tumor Growth and Progression in Ovarian Cancer through the WNT/ -Catenin Pathway

(2012) S. Yoshioka et al.   MOLECULAR CANCER RESEARCH

miR-211 Is a Prosurvival MicroRNA that Regulates chop Expression in a PERK-Dependent Manner

(2012) Nilesh S. Chitnis et al.   MOLECULAR CELL

Breast cancer and microRNAs: therapeutic impact

(2011) Marilena V. Iorio et al.   BREAST

Targeting Liver Cancer: First Steps toward a miRacle?

(2011) Robert F. Schwabe et al.   CANCER CELL

Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells

(2010) Nathan J Bowen et al.   BMC Medical Genomics

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage

(2010) E Bobrovnikova-Marjon et al.   ONCOGENE

MicroRNA Let-7a Inhibits Proliferation of Human Prostate Cancer Cells In Vitro and In Vivo by Targeting E2F2 and CCND2

(2010) Qingchuan Dong et al.   PLoS One

The Regulation of miRNA-211 Expression and Its Role in Melanoma Cell Invasiveness

(2010) Joseph Mazar et al.   PLoS One

Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM

(2010) W. R. Wiedemeyer et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

miR-15a and miR-16-1 in cancer: discovery, function and future perspectives

(2009) R I Aqeilan et al.   CELL DEATH AND DIFFERENTIATION

Association between High miR-211 microRNA Expression and the Poor Prognosis of Oral Carcinoma

(2009) K.-W. Chang et al.   JOURNAL OF DENTAL RESEARCH

PERK Regulates the Proliferation and Development of Insulin-Secreting Beta-Cell Tumors in the Endocrine Pancreas of Mice

(2009) Sounak Gupta et al.   PLoS One

MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer

(2008) N. Yang et al.   CANCER RESEARCH

Multilevel Regulation of Gene Expression by MicroRNAs

(2008) E. V. Makeyev et al.   SCIENCE